Expiratory central airway collapse (ECAC) includes two subtypes: excessive dynamic airway collapse and tracheobronchomalacia.[1] It is manifested by shortness of breath, chronic cough, difficulty in expectorating mucus and repeated respiratory tract infections.[1] The diagnosis is established by dynamic flexible bronchoscopy and computed tomography.[1] Drug treatment focuses on respiratory symptoms and associated diseases such as chronic obstructive pulmonary disease, asthma, gastroesophageal reflux, and paroxysmal vocal cord movements.[1] Selected patients may undergo trial stenting to assess eligibility for tracheobronchoplasty (TBP).[1] A positive response to stenting predicts a successful TBP outcome that improves respiratory symptoms and quality of life.[1] Alternative options include long-term stenting and intermittent positive airway pressure therapy.[1]